(EMAILWIRE.COM, December 28, 2017 ) Middle-East & Africa Monoclonal Antibodies Market was worth $6,065.33 million in 2016 and estimated to be growing at a CAGR of 2.18%, to reach $6,754.65 million by 2021.

View report: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-monoclonal-antibodies-market-1204/

The market is showcasing evident potential in the mentioned forecasting period. MAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules. Middle-East & Africa Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications.

Middle-East & Africa Monoclonal Antibodies market is driven by increasing R & D activities. The development of new molecules is expected to play a prominent role in the future of the market. Rising awareness levels among patients and physicians and an increase in disposable income of the people are the major factors fuelling the growth of the market. However stringent regulatory framework and huge cost and time associated with the identification and development of molecules is a major factor restraining the growth of the market.

Download free sample report: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-monoclonal-antibodies-market-1204/request-sample

The Middle-East & Africa market for Monoclonal Antibodies is broadly segmented into Source, Indication, End User and Application. On the basis of source market is segmented into Murine, Chimeric, Humanized and Human. By source Human mAb`s account for the largest share of the market. Based on Application the market is Segmented to cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders and others. Cancer Vaccines are further sub segmented into Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer and Others.

On the basis of end user, the market is segmented into Hospitals/Clinics, Research Institute and Diagnostic Laboratories. Hospitals is the largest end user segment accounting for a share of approximately XX%. By application global monoclonal antibodies market is segmented into medical and experimental. Based on experimental the market is further sub segmented into Western Blot, ELISA, Radioimmune Assays, Immunofluorescence and others. Geographically, Middle-East & Africa monoclonal antibodies market is segmented into Middle-East and Africa.

Inquire before buying: http://www.marketdataforecast.com/market-reports/middle-east-and-africa-monoclonal-antibodies-market-1204/inquire

Some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland) and Teva Pharmaceutical Industries Ltd. (Israel)

Segmentation
 Based on Source :
• Murine
• Chimeric
• Humanized
• Human.

 Based on Indication :
• Cancer
 Blood Cancer
 Breast Cancer
 Colorectal Cancer
 Lung Cancer
 Pancreatic Cancer
 Others.
• Autoimmune Diseases
• Infectious Diseases
• Cardiovascular Diseases
• CNS Disorders
• Others (Inflammatory, Microbial Diseases, & Other)

 Based on End User :
• Hospitals/Clinics
• Research Institute
• Diagnostic Laboratories.

 Based on Application :
• Medical
• Experimental
 Western Blot
 ELISA
 Radioimmune Assays
 Immunofluorescence
 Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry).

Based on geography, the report contains a wide array of countries covering all around the globe. Countries like USA, Mexico, U.K., Spain, Japan, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant markets for Monoclonal Antibodies Market. For more of regional analysis, check out the following reports.

 Asia-Pacific Monoclonal Antibodies Market
 Europe Monoclonal Antibodies Market
 Middle-East and Africa Monoclonal Antibodies
 North America Monoclonal Antibodies Market
 Latin America Monoclonal Antibodies Market

Some of the major companies dominating the market, by their products include GlaxoSmithKline plc. (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China). Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies.

Scope of the Global Monoclonal Antibodies Market:
• Global, Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the Global region
• To detect major focus areas of industrial growth Segment-level analysis on basis of product on source, indication, application and end-user along with market size forecasts and y-o-y estimations are provided
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• PESTLE and Porter’s Five Forces Analyses that examine the macro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
• An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
• mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
• Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

Checkout other related studies in the Therapeutics section:
Cancer Vaccines Market: http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/

About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product-specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results